Senator Reverend Warnock's Statement On Novo Nordisk's Insulin Price Cut Announcement
March 15, 2023
March 15, 2023
WASHINGTON, March 15 -- Sen. Raphael G. Warnock, D-Georgia, issued the following news release:
U.S. Senator Reverend Raphael Warnock (D-GA) released the following statement after insulin manufacturer Novo Nordisk announced that the company would cut the price of their most popular insulin product by 70%. Earlier in the week, Senator Warnock urged Novo Nordisk to cap out-of-pocket insulin costs for patients at $35 a month. Senator Warnock has championed the effort to cap insulin cost . . .
U.S. Senator Reverend Raphael Warnock (D-GA) released the following statement after insulin manufacturer Novo Nordisk announced that the company would cut the price of their most popular insulin product by 70%. Earlier in the week, Senator Warnock urged Novo Nordisk to cap out-of-pocket insulin costs for patients at $35 a month. Senator Warnock has championed the effort to cap insulin cost . . .